This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Lucy Chard
28 Feb 2023

CPHI Podcast Series: Rare Disease Day – Pharma fulfilling an unmet need

In this podcast Digital Editor Lucy Chard is joined by Rachel Smith of Parexel to discuss the challenges surrounding the development of medicines for rare disease patients. 

This February 28th, we have a special feature episode to mark Rare Disease Day. Rare disease is an oft overlooked field of medicine, but one which is steadily becoming more recognised. 

Rare diseases affect around 300 million people globally. By their nature, rare diseases are incredibly difficult to research and develop medicines for, but this just makes it all the more urgent to fulfil this unmet need for rare disease patients. 

In this podcast I am joined by Rachel Smith; Rachel is the Executive Director, Global Head of Rare Diseases at Parexel (MA, USA). Rachel brings more than a decade of experience in every development phase of rare disease and cell and gene therapy clinical trials to her work with Parexel’s rare disease clients. Previously, she served as Vice President of Clinical Operations, Portfolio Director of Rare Disease, and Global Head of the Cell & Gene Center of Excellence at Veristat LLC (MA, USA). She led programmes in ADA-SCID, Canavan disease, congenital adrenal hyperplasia, Fabry disease, Gaucher disease, metachromatic leukodystrophy, and Wiskott-Aldrich Syndrome. Rachel has expertise in clinical development strategy, novel and adaptive trial design, decentralised trials, and other creative solutions for rare disease products with a non-classical route to market.

We discuss the disparities in healthcare across the world and the impact this has on making treatment for rare diseases accessible; the true meaning of patient advocacy; and the stories of individuals that demonstrate how important work into understanding rare diseases really is. 

The future of rare diseases at CPHI Barcelona

What is the pharma industry doing for individuals affected by rare diseases? Around the world, 300 million people are relying on us. At CPHI Barcelona, you can meet experts in the field and learn about the latest research in this often-neglected field.

Your CPHI Barcelona pass gives you access to all conference sessions, including Future Therapies, as well as the chance to connect in-person with the global pharma supply chain from 24-26 October, at Fira Barcelona Gran Via. Browse the agenda and secure your pass today!

Learn more

Lucy Chard
Digital Editor - Pharma

Related News